LON:TRLS Trellus Health (TRLS) Share Price, News & Analysis → A Silent Invasion of America (From The Freeport Society) (Ad) Free TRLS Stock Alerts GBX 1.70 +0.15 (+9.68%) (As of 06/14/2024 12:34 PM ET) Add Compare Share Share Today's Range 1.55▼ 1.7050-Day Range 1.36▼ 2.2552-Week Range 1.20▼ 9.65Volume7.70 million shsAverage Volume397,711 shsMarket Capitalization£2.75 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsStock AnalysisChartCompetitors Get Trellus Health alerts: Email Address Ad The Freeport SocietyA Silent Invasion of AmericaThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern border is a travesty, but the 'invasion' I've found will have 10 times greater effects on our economy, and ultimately our way of life.Go here to see why. About Trellus HealthTrellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers TrellusElevate, a proprietary HIPAA-compliant technology platform to coordinate and deliver personalized care remotely through telemedicine. Its platform provides patients with access to a care team, educational content resources, and remote monitoring capabilities for the treatment of inflammatory bowel diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis. The company was founded in 2020 and is headquartered in White Plains, New York.Read More TRLS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TRLS Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive TRLS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Trellus Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolLON:TRLS CUSIPN/A CIKN/A Webwww.trellushealth.com Phone800-866-4165FaxN/AEmployees31Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-6,340,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-28.43% Return on Assets-18.41% Debt Debt-to-Equity RatioN/A Current Ratio15.69 Quick Ratio17.11 Sales & Book Value Annual Sales£35,000.00 Price / Sales78.45 Cash FlowGBX 2.24 per share Price / Cash Flow0.76 Book ValueGBX 12 per share Price / Book0.14Miscellaneous Outstanding Shares161,510,000Free FloatN/AMarket Cap£2.75 million OptionableNot Optionable Beta0.13 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesDr. Marla Cindy Dubinsky M.D.Co-Founder, CEO & DirectorDr. Laurie Keefer Ph.D.Co-Founder & Chair of Scientific Advisory BoardMs. Joy Bessenger B.A.Chief Financial OfficerAled StevensonChief Operating OfficerJamey HancockChief Technology OfficerAmy MurphyDirector of Human ResourcesDr. Andres Jimenez M.B.A.M.D., M.S., Chief Medical Information OfficerLeah Conley M.B.A.Head of Global Market Access - Travere Therapeutics & Member of Scientific Advisory BoardMr. Salim Gulamabbas Hamir F.C.A.Company SecretaryMore ExecutivesKey CompetitorsFeedbackLON:FDBKIQ-AILON:IQAIDeepVergeLON:DVRGSensyne HealthLON:SENSEMIS GroupLON:EMISView All Competitors TRLS Stock Analysis - Frequently Asked Questions How have TRLS shares performed in 2024? Trellus Health's stock was trading at GBX 3.25 at the beginning of the year. Since then, TRLS shares have decreased by 47.7% and is now trading at GBX 1.70. View the best growth stocks for 2024 here. How do I buy shares of Trellus Health? Shares of TRLS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:TRLS) was last updated on 6/16/2024 by MarketBeat.com Staff From Our PartnersGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that...Porter & Company | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trellus Health plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Trellus Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.